The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers.
Saved in:
| Title: | The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers. |
|---|---|
| Authors: | Ashton, N. J.1,2,3 (AUTHOR) nicholas.ashton@gu.se, Leuzy, A.4 (AUTHOR), Karikari, T. K.1 (AUTHOR), Mattsson-Carlgren, N.4,5,6 (AUTHOR), Dodich, A.7,8 (AUTHOR), Boccardi, M.9,10 (AUTHOR), Corre, J.11 (AUTHOR), Drzezga, A.12 (AUTHOR), Nordberg, A.13,14 (AUTHOR), Ossenkoppele, R.4,15 (AUTHOR), Zetterberg, H.1,16,17,18 (AUTHOR), Blennow, K.1,16 (AUTHOR), Frisoni, G. B.9,19 (AUTHOR), Garibotto, V.7,20 (AUTHOR), Hansson, O.4,18,21 (AUTHOR) Oskar.Hansson@med.lu.se |
| Source: | European Journal of Nuclear Medicine & Molecular Imaging. Jul2021, Vol. 48 Issue 7, p2140-2156. 17p. 3 Charts. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 150670022 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Ashton%2C+N%2E+J%2E%22">Ashton, N. J.</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> nicholas.ashton@gu.se</i><br /><searchLink fieldCode="AR" term="%22Leuzy%2C+A%2E%22">Leuzy, A.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Karikari%2C+T%2E+K%2E%22">Karikari, T. K.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mattsson-Carlgren%2C+N%2E%22">Mattsson-Carlgren, N.</searchLink><relatesTo>4,5,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dodich%2C+A%2E%22">Dodich, A.</searchLink><relatesTo>7,8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Boccardi%2C+M%2E%22">Boccardi, M.</searchLink><relatesTo>9,10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Corre%2C+J%2E%22">Corre, J.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Drzezga%2C+A%2E%22">Drzezga, A.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nordberg%2C+A%2E%22">Nordberg, A.</searchLink><relatesTo>13,14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ossenkoppele%2C+R%2E%22">Ossenkoppele, R.</searchLink><relatesTo>4,15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zetterberg%2C+H%2E%22">Zetterberg, H.</searchLink><relatesTo>1,16,17,18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Blennow%2C+K%2E%22">Blennow, K.</searchLink><relatesTo>1,16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Frisoni%2C+G%2E+B%2E%22">Frisoni, G. B.</searchLink><relatesTo>9,19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Garibotto%2C+V%2E%22">Garibotto, V.</searchLink><relatesTo>7,20</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hansson%2C+O%2E%22">Hansson, O.</searchLink><relatesTo>4,18,21</relatesTo> (AUTHOR)<i> Oskar.Hansson@med.lu.se</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Nuclear+Medicine+%26+Molecular+Imaging%22">European Journal of Nuclear Medicine & Molecular Imaging</searchLink>. Jul2021, Vol. 48 Issue 7, p2140-2156. 17p. 3 Charts. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=150670022 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00259-021-05253-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 17 StartPage: 2140 Titles: – TitleFull: The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ashton, N. J. – PersonEntity: Name: NameFull: Leuzy, A. – PersonEntity: Name: NameFull: Karikari, T. K. – PersonEntity: Name: NameFull: Mattsson-Carlgren, N. – PersonEntity: Name: NameFull: Dodich, A. – PersonEntity: Name: NameFull: Boccardi, M. – PersonEntity: Name: NameFull: Corre, J. – PersonEntity: Name: NameFull: Drzezga, A. – PersonEntity: Name: NameFull: Nordberg, A. – PersonEntity: Name: NameFull: Ossenkoppele, R. – PersonEntity: Name: NameFull: Zetterberg, H. – PersonEntity: Name: NameFull: Blennow, K. – PersonEntity: Name: NameFull: Frisoni, G. B. – PersonEntity: Name: NameFull: Garibotto, V. – PersonEntity: Name: NameFull: Hansson, O. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: Jul2021 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 16197070 Numbering: – Type: volume Value: 48 – Type: issue Value: 7 Titles: – TitleFull: European Journal of Nuclear Medicine & Molecular Imaging Type: main |
| ResultId | 1 |